FDA's Clinical Trial Oversight Lacking

Of course, there are about 200 inspectors assigned to oversee approximately 350,000 testing sites, so itâEUR(TM)d be virtually impossible to police every site. But the report also found that top officials in Washington downgraded the inspectorsâEUR(TM) findings most of the time and almost never followed up to see if specified corrective actions were taken.

An earlier inspector general report found that inspections focused more on the accuracy of study information and not enough on the protection of human subjects. The new report found that in that regard, nothing has changed.

Not surprisingly, the report essentially concludes that the agency's oversight is disorganized and underfinanced.